| Product Information |
BR-1221_PI_01.pdf
|
| Registration Number |
BR-1221
|
| Generic Name |
Adalimumab
|
| Brand Name |
Humira
|
| Dosage Strength |
40 mg /0.4 mL
|
| Dosage Form |
Solution for Injection (SC)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Tumor Necrosis Factor Alpha (TNF-a) Inhibitors
|
| Packaging |
Each box contains: 2 Type I pre-filled glass syringes with bromobutyl rubber plunger stopper and needle with thermoplastic elastomeric needle shield in blister pack + 2 alcohol swabs
|
| Manufacturer |
Vetter Pharma-Fertigung GmbH & Co. KG
|
| Country of Origin |
Germany
|
| Trader |
N/A
|
| Importer |
Zuellig Pharma Corporation
|
| Distributor |
Zuellig Pharma Corporation
|
| Application Type |
Initial (from Monitored Release)
|
| Issuance Date |
05 August 2022
|
| Expiry Date |
17 July 2027
|